Characteristics of ITP patients
. | . | . | Plt count, × 109/L . | . | Antiplatelet GP antibodies . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|
| Patient no. . | Age, y . | Sex . | . | GCI . | GPIIb/IIIa . | GPIa/IIa . | GPIb/IX . | ||
| 1 | 37 | F | 80 | 3 | Negative | Negative | Negative | ||
| 2 | 22 | F | 2 | 226 | Positive | Positive | Positive | ||
| 3 | 20 | F | 4 | 68 | Negative | Negative | Negative | ||
| 4 | 19 | M | 4 | 84 | Negative | Negative | Negative | ||
| 5 | 28 | M | 9 | 21 | Negative | Negative | Negative | ||
| 6 | 63 | F | 12 | 13 | Negative | Negative | Negative | ||
| 7 | 13 | F | 5 | 54 | Negative | Negative | Negative | ||
| 8 | 41 | F | 10 | ND | ND | ND | ND | ||
| 9 | 17 | F | 5 | 47 | Positive | Negative | Negative | ||
| 10 | 47 | F | 80 | 3 | Negative | Negative | Negative | ||
| 11 | 69 | M | 20 | 11 | Negative | Negative | Negative | ||
. | . | . | Plt count, × 109/L . | . | Antiplatelet GP antibodies . | . | . | ||
|---|---|---|---|---|---|---|---|---|---|
| Patient no. . | Age, y . | Sex . | . | GCI . | GPIIb/IIIa . | GPIa/IIa . | GPIb/IX . | ||
| 1 | 37 | F | 80 | 3 | Negative | Negative | Negative | ||
| 2 | 22 | F | 2 | 226 | Positive | Positive | Positive | ||
| 3 | 20 | F | 4 | 68 | Negative | Negative | Negative | ||
| 4 | 19 | M | 4 | 84 | Negative | Negative | Negative | ||
| 5 | 28 | M | 9 | 21 | Negative | Negative | Negative | ||
| 6 | 63 | F | 12 | 13 | Negative | Negative | Negative | ||
| 7 | 13 | F | 5 | 54 | Negative | Negative | Negative | ||
| 8 | 41 | F | 10 | ND | ND | ND | ND | ||
| 9 | 17 | F | 5 | 47 | Positive | Negative | Negative | ||
| 10 | 47 | F | 80 | 3 | Negative | Negative | Negative | ||
| 11 | 69 | M | 20 | 11 | Negative | Negative | Negative | ||
Normal values: platelet count, 150 × 109/L to 350 × 109/L; GCI, 0.7 ± 0.2.
Plt indicates platelet; GCI, glycocalicin index; GP, glycoprotein; F, female; M, male; and ND, not determined.